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Kevin Varty, MD, FRCS, and Patrick A. Coughlin, MD, FRCS, Cambridge, United Kingdom
Background: Critical limb ischemia (CLI) is a common condition associated with high levels of morbidity and mortality.
Most work to date has focused on surgeon-oriented outcomes such as patency, but there is increasing interest in patient-
oriented outcomes such as mobility and independence.
Objective: This study was conducted to determine the effect of infrainguinal lower limb bypass surgery (LLBS) on
postoperative mobility in a United Kingdom tertiary vascular surgery unit and to investigate causes and consequences of
poor postoperative mobility.
Methods: We collected data on all patients undergoing LLBS for CLI at our institution during a 3-year period and
analyzed potential factors that correlated with poor postoperative mobility.
Results:During the study period, 93 index LLBS procedures were performed for patients with CLI. Median length of stay
was 11 days (interquartile range, 11 days). The 12-month rates of graft patency, major amputation, and mortality were
75%, 9%, and 6%, respectively. Rates of dependence increased fourfold during the ﬁrst postoperative year, from 5%
preoperatively to 21% at 12 months. Predictors of poor postoperative mobility were female sex (P [ .04) and poor
postoperative mobility (P < .001), initially and at the 12-month follow-up. Patients with poor postoperative mobility had
signiﬁcantly prolonged hospital length of stay (15 vs 8 days; P < .001).
Conclusions: Patients undergoing LLBS for CLI suffer signiﬁcantly impaired postoperative mobility, and this is associated
with prolonged hospital stay, irrespective of successful revascularization. Further work is needed to better predict patients
who will beneﬁt from revascularization and in whom a nonoperative strategy is optimal. (J Vasc Surg 2014;59:983-7.)Critical limb ischemia (CLI) is deﬁned as the presence
of chronic ischemic rest pain, ulcers, or gangrene attribut-
able to objectively proven arterial disease.1 Recent esti-
mates suggest that up to 1000 new cases of CLI per 1
million population are diagnosed every year in Europe
and North America and that CLI is associated with high
short-term and longer-term mortality rates.1,2 Revasculari-
zation is required to prevent ultimate limb loss, and
although there is an increasing vogue toward endovascular
intervention, there is strong support for the role of infrain-
guinal lower limb bypass surgery (LLBS).3,4
Traditionalmeasures of the success of LLBS have focused
on indicators of technical success, such as graft patency, limb
salvage, or ankle-brachial pressure index, because these are
easily measured, objective measures. There has been a shift
toward more patient-centered outcome measures tothe Department of Vascular Surgery, Cambridge University Hospitals
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important in conditions such asCLI,where rates of comorbid
disease are high.6 Suchmeasures include quality of life (QOL)
analysis with well-validated disease-speciﬁc QOL tools avail-
able for lower limb ischemia.7 Chetter et al8 were one of the
ﬁrst groups tohighlight thatgraftpatencyequates toan imme-
diate and lasting improvement in health-related QOL, but
such infrainguinal arterial reconstruction is itself a potentially
morbid procedure, and graft patency itself does not guarantee
clinical improvement.9 Other important patient-speciﬁc
outcomes include residential status and mobility reﬂecting
functional outcome. Reﬂecting this change of focus, the
recently published Comprehensive Risk After Bypass
(CRAB)10 score is the ﬁrst risk-scoring tool for LLBS to
include functional status within its scoring algorithm.
No study has yet presented data related to contempo-
rary practice within the United Kingdom (UK) health care
system. Thus, this study aimed to determine the effect of
infrainguinal LLBS on postoperative mobility and to inves-
tigate causes and consequences of poor postoperative
mobility. We also provide the ﬁrst external validation of
the CRAB score as a predictor of outcomes in LLBS.
METHODS
Patients. Data were collected retrospectively on all
patients undergoing infrainguinal LLBS for CLI at
a tertiary vascular surgical unit from January 1, 2009,
to January 31, 2012. Paper and electronic notes were
interrogated in all cases where these were available.
One set of paper notes could not be retrieved, so this983
Table I. Ipsilateral reinterventions in the ﬁrst 12 months
after lower limb bypass surgery (LLBS)
Intervention Grafts, No.
No further intervention 62
Re-look for bleeding 3
Thrombectomy/lysis 8
Upstream/downstream angioplasty 11
Graft angioplasty/patch plasty 15
Redo bypass 4
Table II. Mobility of the cohort preoperatively and
during the postoperative period up to 1 year
Variable No. Independent, % Aided, % Dependent, %
Admission 93 72 23 5
Discharge 93 55 38 7
12 months 82 63 16 21
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that could not be reliably extracted from the electronic
records. The hospital electronic medical records system
is linked to the Ofﬁce for National Statistics for recording
mortality. Information was collected on basic demo-
graphics, basic hematologic and biochemical measure-
ments, comorbidities, presence or absence of tissue
loss, bypass origin and target vessels, graft type, hospital
length of stay, and ambulatory status on admission to and
discharge from the hospital. Presurgical data were then
used to calculate Finnvasc, Project of Ex-Vivo graft Engi-
neering via Transfection III (PREVENT III), Revised
Cardiac Risk Index (RCRI), and CRAB scores to allow
risk prediction of postoperative outcomes.10-13 Details
of these scores are given in Supplementary Table I
(online only).
A cohort of patients underwent multiple bypass proce-
dures. We felt that if subsequent procedures were
#12 months of the previous bypass, the patient might
not have recovered from the previous operation, and
thus determining the baseline for comparisons would be
difﬁcult. As such, a “repeat” operation on the ipsilateral
limb or on the contralateral limb was deemed to be
a new “episode” only if the previous LLBS was performed
at least 1 year previously. Repeat operations within 1 year
of the previous LLBS were excluded. Graft patency was
determined using arterial duplex scanning.
Deﬁnitions of mobility. For the purposes of analysis,
mobility was stratiﬁed into three groups: dependent
patients, who were bed-bound or wheelchair-bound;
aided patients, who were ambulant but with signiﬁcant
dependence on mobility aids, including those who mobi-
lized with a prosthesis, walking frame, or one or more
elbow crutches; and independent patients, deﬁned as those
fully independent from mobility aids or requiring no more
than a walking stick for assistance.
Physiotherapists determined mobility on admission and
discharge. Vascular specialist nurses, physiotherapists, or
surgeons determined mobility at routine 12-month
follow-up assessments. No home visits were made.
Statistical analysis. The primary outcome was inde-
pendent mobility 1 year after surgical revascularization.
Secondary outcomes were graft failure and mortality in-
hospital and 12 months after LLBS, and hospital length
of stay during the index admission. Graft failure was
deﬁned as occlusion of the graft on duplex ultrasound
imaging or contrast computed tomography (CT).
Nonparametric analysis was performed in the R 2.15.2
statistical software (The R Foundation for Statistical
Computing, http://www.r-project.org/foundation/)14 to
assess for univariate predictors of poor postoperative
mobility using the Fisher exact test for categoric variables
and the Mann-Whitney U test for continuous variables.
Multivariate analysis was not performed.
RESULTS
Onehundred procedureswere performedon 90patients
(64 men) with CLI, with 93 bypasses being considered asdistinct index “episodes.”The overallmean6 standard devi-
ation age was 706 11 years. Of the 93 bypasses performed,
51were performed electively, 53were for tissue loss (31with
gangrene and 22 with ulceration only), and the distal bypass
target vessel in 20 was the above-knee popliteal artery.
Further graft-speciﬁc details are given in Supplementary
Tables II and III (online only). Six patients underwent
repeated LLBS during the 1-year follow-up period. Further
details of the lesions treated and the reasons for choosing
LLBS rather than an endovascular intervention are given in
Supplementary Tables IV and V (online only).
The median hospital length of stay was 11 days (inter-
quartile range, 11 days). No patients died before hospital
discharge or #30 days of surgery. Three patients, who
underwent three bypass procedures, were lost to follow-
up #12 months. The 1-year mortality rate was 6% (ﬁve
patients). Two patients progressed to major amputation
during their index admission. At 12 months, 25% of grafts
had occluded, with 9% of patients having progressed to
major amputation. Minor amputations were required in
19 patients, comprising 17 digital amputations and two
forefoot amputations. Within the ﬁrst year of follow-up,
26 patients underwent an endovascular intervention aimed
at maintaining graft patency. Five of these grafts subse-
quently failed despite these interventions. Further details
of reinterventions are given in Table I. Three patients
required contralateral LLBS during the ﬁrst year of
follow-up.
Mobility. On admission, 68 of 93 patients were classi-
ﬁed as independent, 21 as aided, and four were dependent.
At discharge, 51 patients were independent, 35 were aided,
and seven were dependent. Data were available for 82
patients at 12 months, at which point 52 patients were
independent, 13 were aided, and 17 were dependent.
Further breakdown of changes in mobility over the ﬁrst
year of follow-up are given in Table II and the Fig. The
Fig. Change in mobility after lower limb bypass surgery (LLBS). f/u, Follow-up.
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mobile before their initial operation. Three of these
patients remained independent at the 1-year follow-up, one
required the aid of a walking frame, one had amputation
below the knee after repeated graft failure and so was
dependent on a wheelchair, and one died of other causes.
Eight patients were dependent at the 12-month follow-up
despite patent grafts. Of these, three had contralateral
amputations on admission and failed to resume using their
prostheses after surgery, and one went on to have a below-
knee amputation, despite a patent graft, for chronic pain at
11 months. This patient was thus dependent at the 12-
month follow-up but subsequently went on to mobilizewith a prosthesis. The remaining four patients became
dependent as a result of comorbidities.
Factors predictive of postoperative mobility. Poor
mobility on discharge was strongly associated with pro-
longed length of stay and predicted by poor preoperative
mobility (P < .001). Men and current smokers were signif-
icantly more likely to leave the hospital independently
mobile (P ¼ .04 and P ¼ .05, respectively), but the male
cohort was also signiﬁcantly younger (median age, 69 years
vs 78 years for women; P ¼ .002). Patients presenting as an
emergency were less likely to be independently mobile on
discharge, although this failed to reach statistical signiﬁ-
cance (P ¼ .10). Further details are presented in Table III.
Table III. Comparison of preoperative and perioperative
predictors of independent mobility at discharge using
nonparametric assessment of signiﬁcant differences
Predictor
Independent
on discharge
Not
independent
on discharge P
Age, median (range),
years
71 (45-89) 72 (29-90) .46a
Male sex, % 78 57 .04b
Emergency admission, % 37 55 .10b
Current smoker, % 47 26 .05b
Preoperative
independence, %
100 40 <.001b
Below-knee distal target,
%
73 86 .14b
Vein graft, % 65 71 .83b
Finnvasc <2, % 55 50 .68b
PREVENT III <4, % 59 57 1.0b
RCRI <1, % 53 38 .21b
CRAB, mean 6 SD 6.7 6 4.5 9.0 6 4.4 <.001a
Tissue loss, % 54 62 .53b
Length of stay,
median (range), days
8 (2-30) 15 (3-40) <.001a
CRAB, Comprehensive Risk Assessment for Bypass; PREVENT, Edifoli-
gide for the Prevention of Infrainguinal Vein Graft Failure; RCRI, Revised
Cardiac Risk Index; SD, standard deviation.
aMann-Whitney U test.
bFisher exact test.
Table IV. Comparison of predictors of poor mobility at
the 12-month follow-up with nonparametric assessment
of signiﬁcant differences
Predictor
Independent
at 12 months
Not
independent
at 12 months P
Age, median (range), years 70 (45-89) 73 (29-88) .22a
Male sex, % 77 54 .04b
Emergency admission, % 44 46 1.0b
Current smoker, % 42 34 .51b
Preoperative
independence, %
94 43 <.001b
Below-knee distal target, % 79 83 .79b
Vein graft, % 75 66 .47b
Finnvasc <2, % 58 49 .51b
PREVENT III <4, % 62 57 .82b
RCRI <1, % 54 40 .27b
CRAB, mean 6 SD 7.2 6 4.4 8.6 6 5.0 .01a
Tissue loss 48 69 .08b
Length of stay,
median (range), days
8 (2-30) 15 (3-40) <.001a
Graft patent at
12 months, %
88 50 .002b
CRAB, Comprehensive Risk Assessment for Bypass; PREVENT, Edifoli-
gide for the Prevention of Infrainguinal Vein Graft Failure; RCRI, Revised
Cardiac Risk Index; SD, standard deviation.
aMann-Whitney U test.
bFisher exact test.
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ciatedwithpremorbidmobility andprolongedhospital length
of stay during the index admission (P< .001) as well as being
associated with graft failure. Men were still more likely to be
mobile, but the associations with smoking and urgency of
operation had disappeared. Assessment using the PREVENT
III, Finnvasc, and RCRI risk scoring models was not associ-
ated with poor mobility at any time point. In contrast, the
CRAB score was associated with poor postoperative mobility
at discharge (P< .001) and at the 12-month follow-up (P¼
.01). Further details are presented in Table IV.DISCUSSION
Traditional markers of outcome for patients under-
going LLBS have tended to be concerned with mortality,
morbidity, and graft patency.15 These are obviously impor-
tant, but over recent years, increasing weight has been
placed on more patient-related and patient-reported
outcomes.5 These include pain, ulcer healing, residential
status, and postoperative mobility. Patients with CLI are
often elderly, have underlying mobility issues, and the
nature of the surgery can be extensive, with associated
limb-related complications that can hinder postoperative
mobility. This study emphasizes the signiﬁcance of LLBS
with regards to postoperative mobility, with a large number
of patients failing to achieve independent mobility in the
immediate postoperative period. Indeed, the requirement
of walking aids signiﬁcantly increases hospital stay.
Although there was some improvement over the postoper-
ative period with regard to independent mobility at 1 year,the rate of wheelchair dependence in the ﬁrst postoperative
year increased fourfold. This clearly implies a signiﬁcant
additional burden on health care resources.
Women undergoing LLBS for CLI were signiﬁcantly
more likely to have poorer mobility at discharge and at
the 12-month follow-up. This may be partly related to
the women being signiﬁcantly older than their male coun-
terparts. Not surprisingly, graft failure at 1 year was associ-
ated with poor mobility at follow-up, although graft failure
did not automatically lead to amputation.
One surprising ﬁnding was that patients who were still
smoking on admission were more likely to be indepen-
dently mobile on discharge, with this association not
evident at 1 year. It is possible that the initial good mobility
was driven by the desire to leave the ward for regular ciga-
rette breaks, although we are not advocating continued
smoking in this patient cohort.
These results are broadly in keeping with the ﬁndings
of a recent large systematic review that identiﬁed 10 studies
analyzing >3000 patients with CLI.16 The authors found
preoperative mobility predicted postoperative mobility
and that wheelchair dependence increased from 9% in the
preoperative population to 22% at follow-up. In addition,
absent or limited tissue loss, younger age, and long-term
graft patency predicted good mobility, whereas diabetes
and female sex predicted poor mobility.
Infrainguinal LLBS is still a commonly performed
procedure within the UK.17 The results presented in our
study represent real-world experience outside the context
of clinical trials and are likely to reﬂect practice within other
UK centers. The retrospective nature of the study is
JOURNAL OF VASCULAR SURGERY
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capture is sufﬁcient to reach robust conclusions. The rela-
tively small sample size of the study means that negative
results should be interpreted with caution.
It is becoming increasingly evident that patient-related
outcomes are becoming more relevant in daily practice.
Chisci et al18 have developed a patient-orientated scoring
system for revascularization in CLI. Using this, they sug-
gested that up to 60% of patients would beneﬁt from revas-
cularization and that a nonoperative approach, including
palliation, could be indicated in patients with poor preop-
erative living status. This is partly borne out within our
study, where no patient with dependency maintained
long-term mobility. Indeed, eight patients were dependent
at the 12-month follow-up despite patent grafts, high-
lighting the inadequacy of graft patency as a measure of
outcome. Before conﬁning such patients to primary ampu-
tation or palliation, however, in-depth studies are required
to speciﬁcally identify patients who will not beneﬁt from
surgical revascularization, particularly in light of the tech-
nologic advances in endovascular treatments. The correla-
tion of the CRAB score with postoperative mobility is
promising in this regard because it represents a step toward
improving our ability to predict which patients are likely to
have poor functional outcomes, with reasonable predictive
power at discharge. Predictive power in the longer-term
was still not optimal, so although this may represent a useful
tool to direct resources during the inpatient stay, it cannot
be relied on as a guide for longer-term prognosis.
CONCLUSIONS
Our study demonstrates that mobility has signiﬁcant
effects on both initial length of stay and longer-term
outcomes in patients with CLI treated with lower limb
bypass surgery. The implications of this in terms of patient
experience and health care burden make this is an impor-
tant area for further work in a patient population that is
only going to increase in size.
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Supplementary Table I (online only). Summary of risk scores calculated
Scoring System Criteria Scoring
Finnvasc11 Diabetes Each scores 1 point
Coronary artery disease
Foot gangrene
Urgent operation
PREVENT III12 Dialysis dependence 4 points
Tissue loss 3 points
Age >75 years 2 points
Hematocrit #0.3 2 points
Coronary heart disease 1 point
RCRI13 High risk surgery Each scores 1 point
Ischemic heart disease
Congestive cardiac failure
Cerebrovascular disease
Insulin-dependent diabetes mellitus
Creatinine $177 mmol/L
CRAB10 Age >75 years 3 points
Prior amputation/revascularization 3 points
Tissue loss 3 points
Partial functional dependence 3 points
Dialysis dependence 4 points
Recent angina/MI 4 points
Emergency operation 6 points
Total functional dependence 6 points
CRAB, Comprehensive Risk Assessment for Bypass; MI, myocardial infarction; PREVENT III, Project of Ex-Vivo graft Engineering via Transfection III;
RCRI, Revised Cardiac Risk Index.
Supplementary Table II (online only). Details of inﬂow and outﬂow vessels of grafts
Anastomosis
Proximal Distal
CFA SFA/PFA Pop AK pop BK pop Tibioperoneal Foot vein
Grafts 86 4 3 20 43 29 1
AK, Above knee; BK, below knee; CFA, common femoral artery; PFA, profunda femoris artery; SFA, superﬁcial femoral artery.
Supplementary Table III (online only). Conduit type
used for bypassa
Conduit type No.
Long saphenous vein 53
Spliced vein 15
Prosthetic with cuff 16
Prosthetic without cuff 8
aIn one patient it was not possible to determine the conduit type due to
missing medical notes.
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Supplementary Table IV (online only). TransAtlantic
Inter-Society Consensus (TASC) 2 classiﬁcation of
femoropopliteal lesions treated with lower limb bypass
surgery (LLBS)
TASC 2 class
A B C D
Patients 0 10 32 51
Supplementary Table V (online only). Reason for
treating critical limb ischemia (CLI) with lower limb
bypass surgery (LLBS) rather than angioplasty
Indication for bypass No.
Unsuitable for angioplasty (eg, ﬂush SFA occlusion) 39
Failed angioplasty 15
Reoccluded lesion/ulcer still not healing after angioplasty 13
Upstream procedure requiring outﬂow 10
Redo bypass 6
Thrombosed SFA/popliteal aneurysm 4
Surgeon preference 6
SFA, Superﬁcial femoral artery.
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